Quarterly report pursuant to Section 13 or 15(d)

CONDENSED STATEMENTS OF CASH FLOWS

v3.21.1
CONDENSED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Cash flows from operating activities:    
Net loss $ (998) $ (1,242)
Adjustments to reconcile net loss to net cash used in operating activities:    
Share based compensation 114 215
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets (6) 48
Accounts payable and accrued expenses (468) (311)
Accounts payable and accrued expenses - related party 51 119
Net cash used in operating activities (1,307) (1,171)
Cash flows from investing activities:    
Milestone payment for research and development licenses 0 (1,000)
Net cash used in investing activities 0 (1,000)
Cash flows from financing activities:    
Net change in cash (1,307) (2,171)
Cash and cash equivalents, beginning of period 3,132 8,745
Cash and cash equivalents, end of period $ 1,825 $ 6,574